A mathematical model of HiF-1α-mediated response to hypoxia on the G1/S transition

Mathematical Biosciences

Volumn 248, Issue 1, 2014, Pages 31-39

  Bedessem, B ^a   Stephanou A ^a  

^a LABORATOIRE TIMC IMAG   (France)

Author keywords

Cancer; Cell cycle arrest; G1 S transition; HiF 1 ; Hypoxia; Quiescence

Indexed keywords

CANCER; CELL-CYCLE ARREST; G1/S TRANSITION; HYPOXIA; QUIESCENCE;

CELL PROLIFERATION; CELLS; DISEASES; MATHEMATICAL MODELS; TUMORS;

CYTOLOGY;

CYCLIN A; CYCLIN D; CYCLIN E; HYPOXIA INDUCIBLE FACTOR 1ALPHA; STEM CELL FACTOR; OXYGEN; RETINOBLASTOMA PROTEIN;

APOPTOSIS; CANCER; HYPOXIA; NUMERICAL MODEL; TUMOR;

ARTICLE; CALIBRATION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; G1 PHASE CELL CYCLE CHECKPOINT; HYPOXIA; MATHEMATICAL MODEL; MATHEMATICAL PARAMETERS; ORDINARY DIFFERENTIAL EQUATION; PROTEIN SYNTHESIS INHIBITION; SIMULATION; ANIMAL; BIOLOGICAL MODEL; CELL HYPOXIA; HUMAN; MATHEMATICAL PHENOMENA; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CELL HYPOXIA; CYCLIN D; CYCLIN E; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MATHEMATICAL CONCEPTS; MODELS, BIOLOGICAL; NEOPLASMS; OXYGEN; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN;

EID: 84893489829     PISSN: 00255564     EISSN: 18793134     Source Type: Journal    
DOI: 10.1016/j.mbs.2013.11.007     Document Type: Article

References (54)

1. Alarcon T., Byrne H.M., Maini P.K. A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells. J. Theor. Biol. 2004, 229:395.
2. Alarcon T., Jensen H.J. Quiescence: a mechanism for escaping the effects of drug on cell populations. J. R. Soc. Interface 2011, 8:99.
3. Baba M., Hirai S., Yamada-Okabe H., Hamada K., Tabuchi H., Kobayashi K., Kondo K., Yoshida M., Yamashita A., Kishida T., Nakaigawa N., Nagashima Y., Kubota Y., Yao M., Ohno S. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of cyclinD1 expression through hypoxia-inducible factor. Oncogene 2003, 22:2728.
4. Bao B., Ali S., Ahmad A., Azmi A.S., Li Y., Banerjee S., Kong D., Sethi S., Aboukameel A., Padhye S.B., Sarkar F.H. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PLoS One 2012, 7:e50165.
5. Barberis M., Klipp E., Vanoni M., Alberghina L. Cell size at s phase initiation: an emergent property of the G1/S network. PLoS Comput. Biol. 2007, 3:e64.
6. Box A.H., Demetrick D.J. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis 2004, 25:2325.
7. Brdos J.I., Ashcroft M. Negative and positive regulation of HiF-1: a complex network. Biochim. Biophys. Acta 2005, 1755:107.
8. Brown J.M., Wilson W.R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 2004, 4:437.
9. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E., Keshet E. Role of HiF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485.
10. Chen W.T., Huang C.J., Wu M.T., Yang S.F., Su Y.C., Chai C.Y. Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn. J. Clin. Oncol. 2005, 35:207.
11. Csikasz-Nagy A., Battogtokh D., Chen K.C., Novk B., Tyson J.J. Analysis of a generic model of eukaryotic cell-cycle regulation. Biophys. J. 2006, 90:4361.
12. Csiksz-Nagy A. Computational systems biology of the cell cycle. Brief Bioinf. 2009, 10:424.
13. Dai Z.J., Gao J., Ma X.B., Yan K., Liu X.X., Kang H.F., Ji Z.Z., Guan H.T., Wang X.J. Up-regulation of hypoxia inducible factor-1 by cobalt chloride correlates with proliferation and apoptosis in PC-2 cells. J. Exp. Clin. Cancer Res. 2012, 31:28.
14. van Drogen F., Sangfelt O., Malyukova A., Matskova L., Yeh E., Means A.R., Reed S.I. Ubiquitylation of cyclin e requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol. Cell 2006, 23:37.
15. Filippi S., Latini P., Frontini M., Palitti F., Egly J.M., Proietti-De-Santis L. CSB protein is (a direct target of HiF-1 and) a critical mediator of the hypoxic response. EMBO J. 2008, 27:2545.
16. Frei C., Edgar B.A. Drosophila cyclin D/Cdk4 requires HiF-1 prolyl hydroxylase to drive cell growth. Dev. Cell 2004, 6:241.
17. Gardner L.B., Li Q., Park M.S., Flanagan W.M., Semenza G.L., Dang C.V. Hypoxia inhibits G1/s transition through regulation of p27 expression. J. Biol. Chem. 2001, 276:7919.
18. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891.
19. Goda N., Dozier S.J., Johnson R.S. HiF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid. Redox Signal. 2003, 5:467.
20. Goda N., Ryan H.E., Khadivi B., McNulty W., Rickert R.C., Johnson R.S. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol. Cell Biol. 2003, 23:359.
21. Green S.L., Freiberg R.A., Giaccia A.J. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol. Cell Biol. 2001, 21:1196.
22. Hammer S., To K.K.W., Yoo Y.G., Koshiji M., Huang L.E. Hypoxic suppression of the cell cycle gene CDC25A in tumor cells. Cell Cycle 2007, 6:1919.
23. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2:38.
24. Hashimoto O., Shimizu K., Semba S., Chiba S., Ku Y., Yokozaki H., Hori Y. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1-dependent manner in pancreatic cancer cells. Pathobiology 2011, 78:181.
25. Hernandez-Luna M.A., Rocha-Zavaleta L., Vega M.I., Huerta-Yepez S. Hypoxia inducible factor-1 induces chemoresistance phenotype in non-hodgkin lymphoma cell line via up-regulation of Bcl-(xL). Leuk. Lymphoma 2012.
26. Icreverzi A., de la Cruz A.F., Voorhies W.A.V., Edgar B.A. Drosophila cyclin D/Cdk4 regulates mitochondrial biogenesis and aging and sensitizes animals to hypoxic stress. Cell Cycle 2012, 11:554.
27. Jiang B.H., Semenza G.L., Bauer C., Marti H.H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 1996, 271:C1172.
28. Kamat C.D., Green D.E., Warnke L., Thorpe J.E., Ceriello A., Ihnat M.A. Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia. Cancer Lett. 2007, 249:209.
29. Ke Q., Costa M. Hypoxia-inducible factor-1 (HiF-1). Mol. Pharmacol. 2006, 70:1469.
30. Kunz M., Ibrahim S.M. Molecular responses to hypoxia in tumor cells. Mol. Cancer 2003, 2:23.
31. Lesart A.C., van der Sanden B., Hamard L., Esteve F., Stephanou A. On the importance of the submicrovascular network in a computational model of tumour growth. Microvasc. Res. 2012, 84:188.
32. Leshem Y., Halevy O. Phosphorylation of pRb is required for HGF-induced muscle cell proliferation and is p27kip1-dependent. J. Cell. Physiol. 2002, 191:173.
33. Letonqueze O., Lee J., Vasudevan S. Microrna-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells. RNA Biol. 2012, 9:871.
34. Maxwell P.H., Pugh C.W., Ratcliffe P.J. The pvhl-hif-1 system. A key mediator of oxygen homeostasis. Adv. Exp. Med. Biol. 2001, 502:365.
35. Moroz E., Carlin S., Dyomina K., Burke S., Thaler H.T., Blasberg R., Serganova I. Real-time imaging of HiF-1alpha stabilization and degradation. PLoS One 2009, 4:e5077.
36. Novak B., Tyson J.J. A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 2004, 230:563.
37. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HiF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187.
38. Papandreou I., Powell A., Lim A.L., Denko N. Cellular reaction to hypoxia: sensing and responding to an adverse environment. Mutat. Res. 2005, 569:87.
39. Park C., Lee I., Kang W.K. Lovastatin-induced e2f-1 modulation and its effect on prostate cancer cell death. Carcinogenesis 2001, 22:1727.
40. Powathil G.G., Gordon K.E., Hill L.A., Chaplain M.A.J. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model. J. Theor. Biol. 2012, 308:1.
41. Provenzano P.P., Keely P.J. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J. Cell Sci. 2011, 124:1195.
42. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008, 15:678.
43. Royds J.A., Dower S.K., Qwarnstrom E.E., Lewis C.E. Response of tumour cells to hypoxia: role of p53 and NFkB. Mol. Pathol. 1998, 51:55.
44. Salceda S., Caro J. Hypoxia-inducible factor 1alpha (HiF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 1997, 272:22642.
45. Semenza G.L. Targeting HiF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721.
46. G.L. Semenza, Hypoxia-inducible factor 1 (HiF-1) pathway., Sci STKE 2007 (2007) cm8.
47. Semenza G.L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 2012, 33:207.
48. Stacey D.W. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol. 2003, 15:158.
49. Tyson J.J., Novak B. Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J. Theor. Biol. 2001, 210:249.
50. Wen W., Ding J., Sun W., Wu K., Ning B., Gong W., He G., Huang S., Ding X., Yin P., Chen L., Liu Q., Xie W., Wang H. Suppression of cyclin d1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of a549 cells. Cancer Res. 2010, 70:2010.
51. Winston J.T., Pledger W.J. Growth factor regulation of cyclin d1 mrna expression through protein synthesis-dependent and -independent mechanisms. Mol. Biol. Cell 1993, 4:1133.
52. Yang K., Hitomi M., Stacey D.W. Variations in cyclin d1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div. 2006, 1:32.
53. Zhong H., Marzo A.M.D., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59:5830.
54. Zhou W., Dosey T.L., Biechele T., Moon R.T., Horwitz M.S., Ruohola-Baker H. Assessment of hypoxia inducible factor levels in cancer cell lines upon hypoxic induction using a novel reporter construct. PLoS One 2011, 6:e27460.